Vendor, Lexington, KY
Murty Pharmaceuticals, Inc.
UEI DNJBTJ3XBQM6, CAGE 3BJ06
8 awards and $83,535 obligated between April 29, 2024 and August 25, 2026, 100% under full and open competition, against 4.0 offers on average where reported. 7 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $304,455 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$220,920 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 8 |
| Delivery Order | 6 |
Hear when Murty Pharmaceuticals, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Murty Pharmaceuticals, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $92,724
- Soonest
- September 12, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
National Institutes of Health, National Institutes of Health Niaid
Award noticeNAICS 325412Frederick, MD75N95025R00005Awarded to Murty Pharmaceuticals, Inc. for $49,885,703
Posted Jul 87 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95025F00001Delivery Order, August 26, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY25. to 6 - Drug Product Stability Studies. Pop 9/13/25-9/12/26.NAICS 541715, PSC AN12 | $92,724 |
| 75N98026F00001Delivery Order, August 25, 2026, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | FY26. to 7 - Drug Product Stability Studies. Pop 9/13/26-9/12/27.NAICS 541715, PSC AN12 | $92,724 |
| 75N95024F00001Delivery Order, September 12, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY24. to 5 - Drug Product Stability Studies. Pop 9/13/24-9/12/25.NAICS 541715, PSC AN12 | $90,784 |
| 75N95021F00001Delivery Order, September 10, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY21. to 1 - Manufacture of CGMP Methamphetamine HCL for IV Injection. Pop 9/18/21-3/14/25.NAICS 541715, PSC AN12 | $28,223 |
| 75N95023F00001Delivery Order, August 30, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Manufacture of Morphine Sulfate Pellets; Task Order 03, FY23NAICS 541715, PSC AN12 | $0 |
| 75N95021D00024August 22, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder. Idiq. Pop 9/18/21-9/17/26NAICS 541715, PSC AN12 | $0 |
| 75N95026D00003June 24, 2026, Full and Open Competition, 7 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | "eo 14398"; Idiq: Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products (Trnd 3)NAICS 325412, PSC AN12 | $0 |
| 75N95019F00088Delivery Order, April 29, 2024, Full and Open Competition, 3 offers | National Institutes of Health NidaNational Institutes of Health | De-Obligate Remaining Fiscal Year 2019 Funds.NAICS 325412, PSC AN11 | -$220,920 |
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchAN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 9 across 8 awards